STAT3上调AIM2 DNA感应器连接先天免疫与细胞迁移促进上皮肿瘤发生
该研究探讨AIM2在胃癌发生中的作用,发现IL-11细胞因子通过STAT3激活上调肿瘤上皮AIM2表达;AIM2不依赖炎症小体活性,而是与EB1结合促进上皮细胞迁移和肿瘤发生,AIM2和EB1高表达与胃癌患者不良生存独立相关。
要点
- AIM2在胃癌中由IL-11-STAT3信号上调,遗传或治疗性靶向AIM2可抑制gp130 F/F小鼠肿瘤发生
- AIM2促肿瘤功能不依赖炎症小体活性和炎症,而是通过与EB1结合促进上皮细胞迁移
- 胃癌患者肿瘤上皮AIM2和EB1高表达独立关联不良生存
核心结论
- AIM2通过连接细胞因子-STAT3信号、先天免疫和上皮细胞迁移,不依赖炎症小体激活,发挥上皮癌变驱动作用。
研究设计与样本
- 在人胃癌患者队列中评估AIM2表达及临床意义。
- 在gp130 F/F自发性胃癌小鼠模型及人胃癌细胞系异种移植中进行AIM2表达的遗传或治疗性操作。
- 体外和体内确定AIM2在胃肿瘤发生中的生物学作用和机制,包括炎症小体活性及与EB1的功能互作。
主要发现
- AIM2表达在GC小鼠模型和患者肿瘤上皮中由IL-11细胞因子介导的STAT3激活上调。
- gp130 F/F小鼠中遗传和治疗性靶向AIM2抑制肿瘤发生。
- AIM2过表达增加人GC细胞系异种移植的肿瘤负荷。
- AIM2促肿瘤功能不依赖炎症小体活性和炎症,体内外AIM2与EB1物理互作促进上皮细胞迁移和肿瘤发生。
- GC患者肿瘤上皮中AIM2和EB1表达上调独立关联不良生存。
临床怎么用
- AIM2及其与EB1的互作可能作为胃癌上皮肿瘤发生的潜在干预靶点。
- AIM2和EB1在肿瘤上皮的表达或可用于胃癌患者预后评估。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The absent in melanoma 2 (AIM2) cytosolic pattern recognition receptor and DNA sensor promotes the pathogenesis of autoimmune and chronic inflammatory diseases via caspase-1-containing inflammasome complexes. However, the role of AIM2 in cancer is ill-defined. DESIGN: The expression of AIM2 and its clinical significance was assessed in human gastric cancer (GC) patient cohorts. Genetic or therapeutic manipulation of AIM2 expression and activity was performed in the genetically engineered gp130 F/F spontaneous GC mouse model, as well as human GC cell line xenografts. The biological role and mechanism of action of AIM2 in gastric tumourigenesis, including its involvement in inflammasome activity and functional interaction with microtubule-associated end-binding protein 1 (EB1), was determined in vitro and in vivo. RESULTS: AIM2 expression is upregulated by interleukin-11 cytokine-mediated activation of the oncogenic latent transcription factor STAT3 in the tumour epithelium of GC mouse models and patients with GC. Genetic and therapeutic targeting of AIM2 in gp130 F/F mice suppressed tumourigenesis. Conversely, AIM2 overexpression augmented the tumour load of human GC cell line xenografts. The protumourigenic function of AIM2 was independent of inflammasome activity and inflammation. Rather, in vivo and in vitro AIM2 physically interacted with EB1 to promote epithelial cell migration and tumourigenesis. Furthermore, upregulated expression of AIM2 and EB1 in the tumour epithelium of patients with GC was independently associated with poor patient survival. CONCLUSION: AIM2 can play a driver role in epithelial carcinogenesis by linking cytokine-STAT3 signalling, innate immunity and epithelial cell migration, independent of inflammasome activation.
引用
- Dawson RE, Deswaerte V, West AC, et al. STAT3-mediated upregulation of the AIM2 DNA sensor links innate immunity with cell migration to promote epithelial tumourigenesis. Gut. 2021. PMID: 34489308. doi:10.1136/gutjnl-2020-323916
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。